Basit öğe kaydını göster

dc.contributor.authorSvendsen, Anne Louise
dc.contributor.authorDamci, Taner
dc.contributor.authorBalkir, Tanzer
dc.contributor.authorVora, Jiten
dc.contributor.authorEmral, Rifat
dc.date.accessioned2021-03-06T13:11:17Z
dc.date.available2021-03-06T13:11:17Z
dc.identifier.citationDamci T., Emral R., Svendsen A. L. , Balkir T., Vora J., "Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study", BMC ENDOCRINE DISORDERS, cilt.14, 2014
dc.identifier.issn1472-6823
dc.identifier.othervv_1032021
dc.identifier.otherav_f770eeb1-a9c0-497d-a7aa-b908166629f0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/162098
dc.identifier.urihttps://doi.org/10.1186/1472-6823-14-61
dc.description.abstractBackground: The purpose of this analysis is to evaluate the safety and effectiveness of insulin initiation with once-daily insulin detemir (IDet) or insulin glargine (IGlar) in real-life clinical practice in Turkish patients with type 2 diabetes mellitus (T2DM).
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleLower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study
dc.typeMakale
dc.relation.journalBMC ENDOCRINE DISORDERS
dc.contributor.departmentAnkara Üniversitesi , ,
dc.identifier.volume14
dc.contributor.firstauthorID215527


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster